分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

A biomimetic hybrid membrane vesicle nanoplatform attenuates tendinopathy through neuroinflammation modulation and tendon regeneration

Dongxu Li, Wei Huang, Feifei Ni, Wenbo Yang, Xiao Lv, Fashuai Wu, Fei Gao, Yu He, Tingfang Sun, Wei Yu, Zekang Xiong, Chunqing Meng, Hong Wang, Yizhong Peng

Journal:Cell Reports Medicine

IF:14

DOI:10.1016/j.xcrm.2026.102937

PMID:42492519

Published:2026-07-23

research field:病害检测农业生物技术核酸扩增分子诊断植物病理学

Abstract

Tendinopathy is a common condition that causes long-term pain. The inflammatory microenvironment (inflamed soil) promotes the ingrowth of sensory nerves (a key pain trigger) and induces functional impairments in tendon stem/progenitor cells (TSPCs) (dysfunctional seeds). These interconnected processes collectively drive the progression of tendinopathy, which is frequently accompanied by persistent pain. Here, we develop a multifunctional nanoplatform (MSM-DTM) by integrating macrophage-sensory neuron hybrid membrane vesicles (MSM) and decellularized tendon matrix (DTM). MSM, fused from macrophage and sensory neuron membranes, efficiently binds multiple inflammatory cytokines and neuropeptides, thereby reprogramming the inflammatory microenvironment. Moreover, MSM breaks the vicious cycle of inflammation-induced senescence and prevents TSPCs aging. DTM promotes tenogenic differentiation and migration of TSPCs, improving tendon regeneration. In vivo , MSM-DTM improves collagen alignment, regulates macrophage polarization, alleviates pain, and enhances tendon functional recovery. MSM-DTM disrupts the inflammation-senescence positive feedback loop and reconstructs a pro-regenerative microenvironment, offering a promising strategy for tendinopathy.

本文使用的Yeasen产品

购物车
客服
转染试用